US FDA approves Adaptimmune's gene therapy for rare cancer-March 2024-www.financetom.com

US FDA approves Adaptimmune's gene therapy for rare cancer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Adaptimmune's gene therapy for rare cancer

Aug 2, 2024 6:33 AM

Aug 2 (Reuters) - The U.S. Food and Drug Administration

said on Friday it has approved Adaptimmune's

first-of-its-kind gene therapy to treat adult patients with a

type of advanced synovial sarcoma who have received prior

chemotherapy.

Previous page： Why NuCana (NCNA) Shares Are Trading Lower Next page： BRIEF-Keysight Technologies To Buy UK's Spirent Communications For $1.46 Bln

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why NuCana (NCNA) Shares Are Trading Lower

Mar 28, 2024

NuCana plc ( NCNA ) shares are trading lower by 15.2% to $0.26 during Thursday’s session after the company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs) to its ordinary shares from 1:1 to 1:25, effective around April 16. This change is akin to a one-for-twenty-five reverse ADS split and aims to enhance...

BRIEF-Keysight Technologies To Buy UK's Spirent Communications For $1.46 Bln

Mar 28, 2024

March 28 (Reuters) - Keysight Technologies Inc ( KEYS ): * RECOMMENDED CASH OFFER BY KEYSIGHT FOR SPIRENT COMMUNICATIONS PLC * KEYSIGHT TECHNOLOGIES INC ( KEYS ): OFFER IS FOR A CASH CONSIDERATION OF 199 PENCE PER SHARE * KEYSIGHT TECHNOLOGIES INC ( KEYS ): PROPOSED DEAL FOR APPROXIMATELY £1,158 MILLION * KEYSIGHT TECHNOLOGIES INC ( KEYS ): SPIRENT'S BOARD...

DBRS Confirms BCE, Bell Canada's Ratings

Mar 28, 2024

11:44 AM EDT, 03/28/2024 (MT Newswires) -- Morningstar DBRS on Thursday confirmed BCE's (BCE.TO) issuer rating of BBB and Bell Canada's issuer rating of BBB (high). Also, the rating agency confirmed BCE's short-term issuer rating, unsecured debentures credit rating, and all classes preferred shares credit rating as well as the credit ratings of Bell Canada and Bell-MTS Inc. All trends...

FinWise Bancorp Names Jim Noone as President, Appoints Robert Wahlman as CFO

Mar 28, 2024

11:41 AM EDT, 03/28/2024 (MT Newswires) -- FinWise Bancorp ( FINW ) said Thursday it named Jim Noone as president and appointed Robert Wahlman as chief financial officer. Wahlman succeeds Javvis Jacobson, who will stay with the bank as treasurer. Noone has been president of FinWise Bank. Wahlman was most recently CFO of Axiom Bank and Axiom Bancshares. Price: 10.08,...